Colorectal cancer is the third most common malignancy in men and the second most
common cancer in women. Despite the success of screening programs and the …

Colorectal cancer is the third most diagnosed cancer, behind only breast and lung cancer. In
terms of overall mortality, it ranks second due to, among other factors, problems with …

Evidence is limited regarding the effect of diagnosis-to-treatment interval (DTI) on the
survival of colorectal cancer (CRC) patients. In addition, previous studies on treatment delay …

O câncer de cólon e reto apresenta alta incidência mundialmente, porém a letalidade da
doença é maior em países em desenvolvimento. O objetivo deste estudo é analisar fatores …

Purpose The widespread coronavirus disease 2019 (COVID-19) pandemic has resulted in
significant changes in care delivery among radiation oncology practices and has demanded …

Background Timely treatment for colorectal cancer (CRC) is a quality indicator in oncological
care. However, patients with CRC might benefit more from preoperative optimization rather …

Introduction The diagnosis or treatment of breast cancer is sometimes delayed. A lengthy
delay may have a negative psychological impact on patients. The aim of our study was to …

Methods We performed a cross-sectional analysis using data from the National Cancer
Institute Surveillance, Epidemiology, and End Results (SEER) database. Our study …

Background This study examined the associations of socioeconomic status (SES),
race/ethnicity, surgery type, and treatment delays with mortality among colon cancer …

PURPOSE Delays in oncologic time to treatment initiation (TTI) independently and adversely
affect disease-specific mortality. Social Determinants of Health (SDoH) are increasingly …